Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes
By
- AMS
posted
Jun 14, 2021 01:44 PM
0
Recommend
.
0 comments
0 views
Related Content
Red light emitting diode as an adjuvant treatment for epidermal growth factor receptor inhibitors-induced paronychia
- AMS
Added May 24, 2021
Blog Entry
Treatment modalities for pityriasis rubra pilaris subtypes: a review
- AMS
Added Mar 30, 2020
Blog Entry
Cognitive behavioral therapy as an adjuvant therapy in acne excoriée: a randomized controlled clinical trial
- AMS
Added Jun 12, 2020
Blog Entry
New Trial Shows Vaginal Laser Therapy Treatments May Not Work At All
- AMS
Added Dec 02, 2021
Blog Entry
Dupilumab as promising treatment for prurigo nodularis: current evidences
- AMS
Added Feb 16, 2021
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic